Merck to acquire antibiotic resistance specialist Cubist Pharmaceuticals for $9.5bn

Cubist specialises on developing medicines against antibiotic-resistant bacteria, generally known as super bugs.



via IBTimes.co.uk : Articles by Jerin Mathew http://ift.tt/12lFsr4 December 09, 2014 at 01:47PM http://ift.tt/eA8V8J